|
www.streetinsider.com/dr/news.php?id=12306264
Leerink affirms Neovasc Inc. (Nasdaq: NVCN) at Outperform with a price target of $10 following news of an asset sales agreement with Boston Scientific (NYSE: BSX).
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 2 | 35 | Neues Thema Neovasc | ermlitz | ermlitz | 12.03.24 19:53 | |
| 20 | NVCN nach dem 1:100 Split | Nervous | ermlitz | 02.06.21 10:17 | ||
| 6 | 1.151 | NVCN | wennichdaswueste | Skorpion_TH | 25.04.21 02:31 |